Swiss pharma giant Novartis (NOVN: VX) has announced a planned $23 billion investment over five years in US-based ...

Speculation about the US Administration’s views on the Benefits Scheme (PBS) has reconfirmed the sanctity of the PBS as the ...

Johnson & Johnson has announced new data from an analysis modelling long-term progression free survival (PFS) in transplant ...

US mRNA specialist Moderna has announced that the German Standing Committee on Vaccination (STIKO) has issued a ...

Indian drugmaker Sun (BSE: 524715) shares were buzzing in trade on the last trading day of the week to April 11, rising as ...

US biotech giant Amgen (Nasdaq: AMGN) today announced a significant breakthrough with its global Phase III DeLLphi-304 ...

US biotech Imbria Pharmaceuticals has raised $57.5 million in a series B financing round to fund a new mid-stage trial of its ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s (LSE: AZN) Truqap ...

Late Thursday, the US Food and Drug Administration revealed it is taking a ground-breaking step to advance public health by ...

US biopharma company Palatin Technologies (NYSE American: PTN) is at risk of being removed from the NYSE American exchange ...

The US Centers for Medicare & Medicaid Services (CMS) has announced action intended to preserve the core mission of the ...